Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 10.10% vs 36.24% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is -89.39% vs 52.45% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is -43.79% vs 36.08% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is -25.00% vs 12.00% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
Compare Quarterly Results Of Frontier Biotechnologies, Inc. (China) With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 47.52% vs 7.07% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 10.10% vs 36.24% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -17.48% vs -20.63% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -89.39% vs 52.45% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -37.05% vs -19.47% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -43.79% vs 36.08% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -8.70% vs -4.17% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -25.00% vs 12.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






